Hood R R, Vreeland W N, DeVoe D L
Department of Bioengineering, University of Maryland, College Park, MD, USA.
Lab Chip. 2014 Sep 7;14(17):3359-67. doi: 10.1039/c4lc00390j.
Microfluidic-directed formation of liposomes is combined with in-line sample purification and remote drug loading for single step, continuous-flow synthesis of nanoscale vesicles containing high concentrations of stably loaded drug compounds. Using an on-chip microdialysis element, the system enables rapid formation of large transmembrane pH and ion gradients, followed by immediate introduction of amphipathic drug for real-time remote loading into the liposomes. The microfluidic process enables in-line formation of drug-laden liposomes with drug : lipid molar ratios of up to 1.3, and a total on-chip residence time of approximately 3 min, representing a significant improvement over conventional bulk-scale methods which require hours to days for combined liposome synthesis and remote drug loading. The microfluidic platform may be further optimized to support real-time generation of purified liposomal drug formulations with high concentrations of drugs and minimal reagent waste for effective liposomal drug preparation at or near the point of care.
微流控引导的脂质体形成与在线样品纯化及远程药物装载相结合,用于单步连续流合成含有高浓度稳定装载药物化合物的纳米级囊泡。该系统使用芯片上的微透析元件,能够快速形成大的跨膜pH和离子梯度,随后立即引入两亲性药物以实时远程装载到脂质体中。微流控过程能够在线形成药物与脂质摩尔比高达1.3的载药脂质体,芯片上的总停留时间约为3分钟,与传统批量方法相比有显著改进,传统方法进行脂质体合成和远程药物装载需要数小时至数天时间。微流控平台可进一步优化,以支持实时生成高浓度药物且试剂浪费最小的纯化脂质体药物制剂,以便在护理点或其附近有效地制备脂质体药物。